Cydar Medical Ltd raises €10.5m in Serie...Cambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust more ➔
Upping sustainability in pharma packagingHow to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023. more ➔
financingEvonetix extends Series B financing to US$...British Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital. more ➔
financingGermany’s Curevac offers common shar...mRNA vaccine pioneer CureVac N.V. has announced that it will sell US$200m of its common shares in an underwritten public offering. more ➔
partnershipsChong Kun Dang Pharm licences Synaffix ADC...South Korean Chong Kun Dang Pharm has licenced access to Amsterdam-based Synaffix BV’s propietary ADC platform. more ➔
Clinical trialsNew EU stakeholder platform to speed up cl...A new platform is set to facilitate the exchange of information on the optimisation of the electronic reporting system CTIS. more ➔
Novel Food Ultra-processed foods increase risk for ca...British researchers have linked higher consumption of ultra-processed foods to an increased risk of developing and dying from cancer. more ➔
partnershipLonza collaborates with Asher Biotherapeut...Asher Biotherapeutics Inc has expanded its manufacturing agreement with Lonza to include the manufacturing of AB248. more ➔
partnershipEvotec and Janssen team up in immunoncolog...Evotec SE and Janssen Biotech Inc have agreed to co-develop targeted immuno-oncological therapies. more ➔
pixabay.com/SD-PicturesClimate changeEvidence of deliberate climate damageA new study adds weight to ongoing legal and political investigations against ExxonMobil for deliberate climate malfeasance. more ➔
pixabay.com/SD-Pictures